Jasper therapeutics inc. jspr
Web10 apr. 2024 · Shares of Jasper Therapeutics Inc. soared 106.2% in volatile morning trading, enough to pace the Nasdaq's gainers, after Oppenheimer analyst Jay Olson's … Web5 apr. 2024 · More Financials. Company. Jasper Therapeutics, Inc., formerly Amplitude Healthcare Acquisition Corporation, is a biotechnology company focused on hematopoietic cell transplant therapies. The Company has developed programs, such as JSP191, an anti-CD117 monoclonal antibody, which is in clinical development as a conditioning agent …
Jasper therapeutics inc. jspr
Did you know?
Web13 apr. 2024 · REDWOOD CITY, Calif., April 13, 2024 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on … Web10 apr. 2024 · 东方财富网研报中心提供沪深两市最全面的上市公司公告信息，第一时间提供各上市公司最新公告，深入解析上市公司最新变化、重大事项。最大程度减少个人投资者与机构之间信息上的差异，使个人投资者更早的了解到上市公司基本面变化。
WebDora D Robinson, age 70s, lives in Leavenworth, KS. View their profile including current address, phone number 913-682-XXXX, background check reports, and property record … Web13 apr. 2024 · Furthermore, Jasper Therapeutics Inc. (JSPR)’s average true range (ATR) is 0.13. The company’s stock has been forecasted to trade at an average price of $6.21 over the course of the next 52 weeks, with a low of $4.00 and a high of $8.00. Based on these price targets, the low is -173.97% off current price, whereas the price has to move -447. ...
Web14 feb. 2024 · About Jasper Therapeutics, Inc. 2200 BRIDGE PARKWAY SUITE NO. 102, REDWOOD, California, 94065, United States +1 650 549-1400 … WebJasper Therapeutics Inc. 2200 Bridge Parkway. Suite 102. Redwood City, California 94065. Phone 1 650 549-1400. Industry Biotechnology. Sector Health Care/Life Sciences.
WebWhat this means: Jasper Therapeutics Inc. (JSPR) gets an Overall Rank of 60, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value.
Web4 feb. 2024 · Individual investors among Jasper Therapeutics, Inc.'s (NASDAQ:JSPR) largest shareholders, saw gain in holdings value after stock jumped 11% last week Read full article Simply Wall St hidapi hid_openWebJasper Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in enabling cures through hematopoietic stem cell therapy. It focuses on the development and commercialization of safer, stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of … ezetrol cenaWebJasper Therapeutics’ management team is composed of experienced biopharma industry veterans with extensive track records in drug development and commercialization. With … ezetrol bnfWeb마감 후 결합된 회사는 Jasper Therapeutics, Inc.로 운영되며 2024년 9월 27일경에 의결권 있는 보통주와 신주인수권의 주식이 시장에서 거래를 시작할 것으로 예상됩니다. 나스닥 … hidapi hidWeb10 apr. 2024 · Jasper Therapeutics Appoints David Hinds as Senior Vice President, Development Operations. REDWOOD CITY, Calif., April 10, 2024 (GLOBE NEWSWIRE) … hidapi libraryWeb10 apr. 2024 · Jasper Therapeutics Inc. (JSPR) full year performance was -56.12%. Price records that include history of low and high prices in the period of 52 weeks can tell a lot … hidapi i2cWeb5 apr. 2024 · The average price predicted for Jasper Therapeutics Inc. (JSPR) by analysts is $6.21, which is $4.63 above the current market price. The public float for JSPR is 96.44M, and at present, short sellers hold a 3.15% of that float. On April 05, 2024, the average trading volume of JSPR was 2.74M shares. The artificial intelligence (AI) revolution is ... hidapi.h